Preprint
Article

Multiple Natural Approaches of Salix alba

Altmetrics

Downloads

166

Views

109

Comments

0

Submitted:

29 March 2024

Posted:

29 March 2024

You are already at the latest version

Alerts
Abstract
Abstract: The Willows, belonging to the genus Salix, encompass a vast array of species and hybrids, totaling between 330 to 500 species along with approximately 200 hybrids. These plants are found across continents such as Africa, North America, Europe, and Asia, exhibiting diverse forms ranging from trees to shrubs and prostrate plants. Traditionally, Willows have been utilized in folk medicine due to their rich reservoir of biologically active compounds, with salicin being a notable example, serving as a prodrug for salicylic acid.The chemical composition of Willows is highly diverse, with 322 secondary metabolites identified thus far. These include various classes such as flavonoids (94 types encompassing flavonols, flavones, flavanones, isoflavones, flavan-3-ols like catechins and procyanidins, chalcones, dihydrochalcone, anthocyanins, and dihydroflavonols), phenolic glycosides (76), organic acids (28), non-phenolic glycosides (17), sterols, and terpenes (17), simple phenolics (13), lignans (7), as well as volatiles and fatty acids (69). This rich chemical di-versity underpins the various pharmacological activities exhibited by Willows. The pharmacological properties attributed to Willows are extensive and include analgesic, an-ti-inflammatory, antioxidant, anticancer, cytotoxic, antidiabetic, antimicrobial, antiobesity, neuroprotective, and hepatoprotective effects. These properties make Willows a subject of con-siderable interest in the fields of medicine and pharmacology. In summary, Willows represent a valuable natural resource with a diverse chemical composition and a wide range of pharmacological activities. This study aimed to enhance our comprehension of the medicinal characteristics of willow bark extract, focusing on its antimicrobial properties. This investigation holds significance in validating the traditional usage of willow bark and investi-gating its potential utility in contemporary medicine.
Keywords: 
Subject: Medicine and Pharmacology  -   Medicine and Pharmacology

1. Introduction

The use of plants for medicinal purposes has indeed been a practice dating back to ancient civilizations. Plants contain a myriad of bioactive compounds that have been utilized by humans for treating various ailments and promoting health. With the emergence of pharmaceutical chemistry in the 19th century, the exploration of plant-derived substances for drug development intensified [1,2].
One notable example of a plant with medicinal properties is white willow (Salix alba L.), a member of the genus Salix and the family Salicaceae. Willows are a diverse group of plants, ranging from small shrubs to towering trees, with white willow typically falling on the smaller end of the spectrum. White willow, also known as salicin willow, has a long history of use for its health benefits, spanning thousands of years.
Salicaceae, commonly known as the Willow and Poplar family, has undergone taxonomic revisions to encompass additional genera beyond its traditional members, Populus (poplar) and Salix (willow). While traditionally limited to Northern temperate regions and characterized by the presence of catkins, the family now includes many tropical members from the Flacourtiaceae family, which do not produce catkins[3,4].
This expansion has increased the family’s diversity to approximately 56 genera and 1,220 species, as of 2016.
Members of the Salicaceae family are renowned for their rapid growth, with many species being trees or shrubs. They hold significant economic value due to their versatility:
Salicaceae species are cultivated for their wood, which is used in various applications such as construction, furniture making, and woodworking.
The fast-growing nature of these trees makes them suitable for paper production, contributing to the pulp and paper industry.
The flexible twigs of willow species are utilized in crafts such as basket weaving, caning, and manufacturing woven fences and lattices.
Historically, Salicaceae species have been employed for making items like fences, snowshoes, arrow shafts, fish traps, whistles, nets, and rope.
They serve as a source of renewable energy, providing biomass fuel for heating and power generation.
Many Salicaceae species are cultivated for their aesthetic appeal in gardens and landscapes.
These plants play a role in environmental enhancement by aiding in soil erosion control. Their extensive root systems help stabilize soil in areas prone to erosion, making them valuable for land reclamation and restoration projects.
The active compound in white willow, salicin, has been recognized for its anti-inflammatory and analgesic properties. It is chemically similar to aspirin and serves as a precursor to the synthesis of acetylsalicylic acid, the active ingredient in aspirin. Due to its ability to alleviate pain and reduce inflammation, white willow has been traditionally employed to treat conditions such as headaches, muscle pain, and arthritis.
Research conducted on white willow has provided insights into its pharmacological effects and potential therapeutic applications. Studies have suggested its efficacy in managing various forms of pain and inflammation, often with fewer side effects compared to synthetic alternatives.
Overall, white willow exemplifies the rich tradition of utilizing plant-derived remedies for healing purposes, demonstrating the ongoing relevance of natural products in modern healthcare practices[5,6].
White willow (Salix alba) indeed has a rich history of medicinal use dating back thousands of years, as you’ve outlined. The use of its bark, containing salicin, for pain relief and inflammation management was widespread across various ancient civilizations, indicating its efficacy and value in traditional medicine.
The mention of Hippocrates recommending chewing willow bark and using willow leaves for childbirth pain demonstrates the recognition of its analgesic properties since ancient times. Furthermore, its use in treating a variety of ailments such as rheumatic pain, back pain, toothache, menstrual cramps, sore throat, fever, and headache highlights its versatility in addressing different types of pain and inflammatory conditions.
Modern research has also validated many of these traditional uses of white willow bark. It’s recognized for its anti-inflammatory and analgesic effects, attributed mainly to salicin’s conversion to salicylic acid in the body, which shares pharmacological similarities with aspirin.
However, it’s essential to note that while white willow bark can offer relief for various conditions, it may not be suitable for everyone, particularly those with certain medical conditions or allergies. As with any herbal remedy, it’s advisable to consult with a healthcare professional before use, especially if you’re pregnant, nursing, or taking other medications [7,8].
The study conducted aimed to explore various aspects of willow bark’s medicinal properties. Specifically, they investigated the antimicrobial activity of ethanol extract from Salix alba (white willow) bark.
The antimicrobial activity assessment likely involved testing the extract against various microorganisms to determine its effectiveness in inhibiting their growth. This is particularly relevant given the historical use of willow bark in traditional medicine for treating infections.
Additionally, determining the total phenolic content and antioxidant activity provides insights into the extract’s chemical composition and potential health benefits. Phenolic compounds are known for their antioxidant properties, which play a crucial role in protecting cells from oxidative damage and reducing the risk of various diseases.
Overall, this study aimed to contribute to the understanding of the medicinal properties of willow bark extract, particularly in terms of its antimicrobial and antioxidant activities. Such research is essential for validating its traditional use and exploring its potential applications in modern medicine[6].

2. Materials and Methods

2.1. Materials

2.1.1. Phytochemistry

There are phytoconstituents or secondary metabolites found in the genus Salix, commonly known as willow trees.
Flavonoids are a diverse group of plant secondary metabolites known for their antioxidant properties and various health benefits. They are commonly found in fruits, vegetables, and beverages such as tea and wine.
Glycosides are compounds where a sugar molecule is attached to a non-sugar moiety. They can be further classified into phenolic glycosides (glycosides containing a phenolic group) and non-phenolic glycosides.
Procyanidins are oligomeric flavonoids, also known as condensed tannins. They are found in various plants and are known for their antioxidant properties.
Organic acids such as citric acid, malic acid, and tartaric acid are commonly found in plants. Their derivatives may include esters, salts, and other compounds formed from organic acids.
Phenolic compounds are characterized by the presence of a phenol group. They have diverse roles in plants, including defense against pathogens and environmental stressors.
Sterols are a type of lipid that play structural roles in cell membranes. Terpenes are a large class of compounds derived from isoprene units, with diverse biological activities.
Lignans are phenolic compounds found in plants, particularly in the cell walls. They have antioxidant and estrogenic properties.
Volatile compounds are organic molecules with low molecular weights that evaporate easily at room temperature. Fatty acids are long-chain carboxylic acids commonly found in fats and oils [9].

2.1.2. Flavonoids

The distribution of various flavonoids across different species of the Salix genus, including their occurrence in different plant parts such as leaves, roots, and bark [10,11].
Salix species contain a wide variety of flavonoids, including flavones, flavonols, flavanones, dihydroflavonols, isoflavones, chalcones, dihydrochalcones, flavan-3-ols, and anthocyanins.The highest diversity of flavonoid classes was detected in leaves with rare occurrence in roots.
Flavones, such as apigenin and its glycosides, are major constituents of S. acutifolia, S. matsudana, and S. babylonica leaves and roots.Chrysoeriol and its derivatives are major constituents of S. babylonica, S. matsudana, and S. subserrata leaves [12].
Acylated luteolin glucosides are characteristic of S. gilgiana leaves.Kaempferol and its derivatives are prominent in S. bordensis, S. babylonica, and S. integra × S. suchowensis.
Angeloxyflavone and isoflavones are markers for S. cheilophila twigs.
Sulfated flavanones and dihydroflavonols accumulate in S. integra × S. suchowensis young stems[.
The bark of willows contains the highest number of chalcones, catechins, procyanidins, and anthocyanins.Chalcones accumulate in the bark of S. daphnoides, S. elbursensis, S. acutifolia, and S. rubra. Catechins, epicatechin, and various procyanidins are major constituents of S. sieboldiana bark.Procyanidins are also significant in S. daphnoides bark.
Anthocyanins are found in the bark of several Salix species, including S. purpurea, S. alba, S. phylicifolia, S. nigricans, S. calodendron, S. viminalis, S. triandra, and S. amygdalina [13] (Figure 1).

2.1.3. Phenolic Glycosides

It’s important the classification and distribution of phenolic glycosides within the Salicaceae family, particularly focusing on the genus Salix [14].
These glycosides play important roles as secondary metabolites and can serve as taxonomic markers for different Salix species. The presence of specific glycosides like salicin, tremuloidin, and tremulacin, as well as others such as acmophyllin A and B, chaenomeloidin, cochinchiside, lasiandrin, leonuriside, and salicin-7-sulfate, can help distinguish between various Salix species [15,16].
Furthermore, the identification of certain glycosides, such as acutifoliside and 1,2-cyclohexanediol glycosides, serves as chemical markers for specific parts of Salix plants, like juvenile stems or twigs, aiding in their characterization and classification [17,18].
Overall, the presence and distribution of these phenolic glycosides provide valuable insights into the taxonomy and phytochemistry of Salix species [19] (Figure 2).

2.1.4. Non-Phenolic Glycosides

In S. triandra L. x dasyclados Wimmer Wood, non-phenolic glycosides (compounds 172, 173, 174, 175, 176, 182–188) were identified as major constituents [19].
In S. arbusculoides Andersson twigs, compounds 170 and 171 are reported as major constituents [20].Certain Salix species are characterized by the accumulation of 1,2-cyclohexanediol glycosides.
Figure 3. Structures of reported non-phenolic glycosides from genus Salix.
Figure 3. Structures of reported non-phenolic glycosides from genus Salix.
Preprints 102587 g003

2.1.5. Organic Acids

Phenolic acids are in various Salix species, which can occur in either free or esterified forms, such as benzyl, cinnamyl, or phenyl ethyl esters. These aromatic acids can be derivatives of benzoic or cinnamic acid.
Benzoic acid derivatives: examples include p-hydroxybenzoic, p-anisic, gallic, salicylic, gentisic, vanillic, 2-amino-3-methoxy benzoic, and protocatechuic acids.
Hydroxycinnamic acid derivatives: these include p-coumaric, caffeic, isoferuolic, and feruolic acids.
Specific compounds and their occurrences in different Salix species are mentioned:
S. purpurea L. and S. alba L. bark were found to contain the highest number of organic acids, including compounds 192–194, 198–200, and 214 [21].
S. tetrasperma Roxb. flowers and bark contain compounds 197, 202, 203, 204, 205–206, 208, 209, and 215 [22].
Figure 4. Structures of reported organic acids from genus Salix.
Figure 4. Structures of reported organic acids from genus Salix.
Preprints 102587 g004

2.1.6. Simple Phenolics

There are a variety of simple phenolic compounds found within the genus Salix, including phenolic acids and their derivatives.
Accumulation of salicyl alcohol (compound 228):this compound serves as the basic nucleus for salicinoids,identified in: S. capensis Thunb. Bark [23],S. acutifolia Willd. Bark [24],S. subserrata Willd. Bark [25],S. caprea L. inflorescence [26].
Accumulation of different simple phenolics in S. caprea L. wood:aucuparin (compound 218),methoxyaucuparin (compound 219),coniferyl alcohol (compound 221),p-coumaryl alcohol (compound 222),4,2′-dihydroxy-3,5-dimethoxybiphenyl (compound 223),sinapylaldehyde (compound 229),identified in S. caprea L. wood [27].
Figure 5. Structures of reported simple phenolics from genus Salix.
Figure 5. Structures of reported simple phenolics from genus Salix.
Preprints 102587 g005

2.1.7. Sterols and Terpenes

Highest number of sterols and triterpenes are detected in:
S. cheilophila C. K. Schneid. twigs: this species exhibited the highest number of sterols and triterpenes [28].
S. tetrasperma Roxb. bark, leaves, and flowers:significant amounts of sterols and triterpenes were found in different parts of this species [29].
S. subserrata Willd. leaves: this species also showed the presence of sterols and triterpenes [30].
S. denticulate aerial parts: detection of sterols and triterpenes was reported in the aerial parts of this species [31].
S. babylonica L. roots: sterols and triterpenes were found in the roots of this species [32].
S. subserrata Willd. bark and leaves: both bark and leaves of this species contained sterols and triterpenes [33].
Specific constituents found in S. cheilophila C. K. Schneid. twigs:
Phytane and pimarane diterpene were identified as major constituents in the twigs of this species [28].
Figure 6. Structures of reported sterols and terpenes from genus Salix.
Figure 6. Structures of reported sterols and terpenes from genus Salix.
Preprints 102587 g006

2.1.8. Lignans

The isolation of lignan derivatives from Salix alba L. bark, as well as the detection of various lignans in the biomass of five willow species cultivated in Quebec, Canada.
Isolation from S. alba L. bark:sisymbrifolin, a lignan derivative (compound 247), was isolated from the bark of Salix alba L.[34].
Detection in the biomass of five willow species in Quebec, Canada:pinoresinol (compound 248),lariciresinol (compound 249),secoisolariciresinol (compound 250),7-hydroxymatairesinol (compound 251),medioresinol (compound 252),lariciresinol-sesquilignan (compound 253).
These lignans were detected in the biomass of five willow species cultivated in Quebec, Canada [35].
Figure 7. Structures of reported lignans from genus Salix.
Figure 7. Structures of reported lignans from genus Salix.
Preprints 102587 g007

2.1.9. Volatiles

Terpenes (hemi-, mono-, and sesqui-terpenes) and non-terpene compounds (aliphatic and aromatic acids, their esters, carbonyl compounds, and hydrocarbons), in the genus Salix identified in the genus Salix:hemi-, mono-, and sesqui-terpenes,aliphatic and aromatic acids,esters,carbonyl compounds,hydrocarbons.
There are highest percent of volatiles and fatty acids reported in certain parts of specific Salix species:
S. caprea L. inflorescence: the highest percentage of volatiles and fatty acids was reported in the inflorescence of this species [26].
Leaves of S. egyptiaca L., S. babylonica L., and S. alba L.: high percentages of volatiles and fatty acids were reported in the leaves of these species [36].
Figure 8. Structures of reported volatiles and fatty acids from genus Salix.
Figure 8. Structures of reported volatiles and fatty acids from genus Salix.
Preprints 102587 g008

2.1.10. Pharmacological Activity

Are well know the traditional use of various Salix species and their isolated compounds, such as salicylic acid and salicin, in folk medicine to treat various ailments including rheumatic diseases, back pain, toothache, headache, and menstrual cramps. Additionally, it mentions the diverse range of biological activities exhibited by Salix species and their compounds, including analgesic, anti-inflammatory, antioxidant, anticancer, cytotoxic, antidiabetic, antimicrobial, anti-obesity, neuroprotective, and hepatoprotective activities.
Specifically, salicylic acid is noted for its effects on cyclooxygenases (COX I, II), which are enzymes crucial for the synthesis of prostaglandins, molecules involved in inflammation and pain regulation [37].

2.1.11. Anti-Inflammatory Activity

Inflammation and its consequences: Inflammation is a common response to various stimuli such as microbial infection and injury. While inflammation is essential for controlling infection and promoting tissue repair, unresolved inflammation can contribute to the pathogenesis of diseases like atherosclerosis, obesity, cancer, and inflammatory bowel disease [38].
Anti-inflammatory effects of Salix extracts:
S. tetrasperma Roxb.: hydroalcoholic extract of S. tetrasperma Roxb. demonstrated anti-inflammatory effects in a rat paw edema model induced by carrageenan. It inhibited cyclooxygenases (COX-1, COX-2), lipoxygenase (LOX), and reduced levels of tumor necrosis factor-alpha (TNF-a) and nuclear factor kappa B (NF-κB)[39].
S. canariensis: oral administration of S. canariensis extract showed dose-dependent anti-inflammatory activities, attributed to pentacyclic triterpenes and polyphenolics [40].
S. caprea L.: identified as a potent cyclooxygenase inhibitor [41].
S. subserrata Willd. and S. tetrasperma Roxb.: exhibited anti-inflammatory effects against carrageenan-induced hind paw edema due to the presence of phenolic glycosides, especially salicin, as well as flavonoids like luteolin, quercetin, and rutin [42].
S. matsudana Koidz.: Methanol extract of S. matsudana Koidz. leaves showed inhibitory activities against cyclooxygenases (COX-1 and COX-2) due to the presence of matsudone, luteolin 7-O-glucoside, and 4′,7-dihydroxyflavone [43].
These findings suggest that Salix extracts possess significant anti-inflammatory properties, potentially attributed to various bioactive compounds present in different species.

2.1.12. HPLC Method

Salicin, found in willow bark, has garnered attention for its therapeutic properties, particularly its anti-inflammatory effects.
Single drug therapyis focusing on the use of a single medication for treating a particular condition, has a long history dating back to ancient times [44,45]. It’s widely accepted by physicians today for various diseases.
With the increased use of herbal remedies alongside conventional medications, understanding interactions between herbs and drugs has become crucial in clinical practice to ensure safety and efficacy.
Developing a marker profile is vital for quality control and scientific validation of single drugs. This ensures consistency in composition and potency, aiding in reliable therapeutic outcomes.
It’s described as the metabolic precursor of salicylic acid, possessing anti-inflammatory properties. Salicin is an alcoholic beta-glycoside containing D-glucose, found in willow barks, particularly in Salix alba L (White Willow). It’s noted as a weaker forerunner of aspirin [46].
Willow bark contains various chemical compounds, including glycosides (such as salicin), tannins, aromatic aldehydes and acids, salicyl alcohol (saligenin), and flavonoids [47,48,49,50,51]. These constituents contribute to its pharmacological effects.
Salicin exhibits antipyretic and analgesic effects, making it useful in treating fever and conditions like arthritis [46]. Its similarity to aspirin in action (Figure 9).

2.2. Methods

HPLC was performed using an Agilent EZChrom Elite system equipped with a DAD detector and a HiCHROM LiChrosorb 100 RP-18 column, 10 μm particle (4.6 x 250 mm).
Extraction of salicylic derivatives: for the analysis of the samples represented by branches of willow
The sample (1 g) was extracted with 8 mL of a solution consisting of a part of 4.2 g/L NaOH solution and a part of methanol. The mixture was stirred at 60°C at reflux for 60 min. After cooling, 0.4 mL of 10 g/L HCl solution was added and the mixture was centrifuged at 9000 rpm for 5 minutes. The supernatant was diluted to 10 mL with a mixture of equal volumes of methanol and high purity water. Before HPLC analysis, the samples were filtered with a PA filters.
Figure 10. Concentration of Salicin from Salix alba bark from. Olt district(Romania).
Figure 10. Concentration of Salicin from Salix alba bark from. Olt district(Romania).
Preprints 102587 g010
Figure 11. Concentration of Salicin from Salix babylonica bark from. Olt district(Romania).
Figure 11. Concentration of Salicin from Salix babylonica bark from. Olt district(Romania).
Preprints 102587 g011
Salicin derivatives are the main constituents of willow bark and can be quantified as salicin equivalents. According to the Monograph of the European Pharmacopoeia [3] and the Evaluation Report of the European Medicines Agency [52], the content of salicin derivatives in the bark of different species of willow varies from 0.5 to 10%. However, quality standards involve at least 1.5%.
Although willow bark remains the main source of salicin.

3.2.1. Extraction Method for a Aqueous Extracts

We prepare the aqueous extracts from Salix alba bark.
Preparation of stock aqueous extracts:10 grams of air-dried and milled plant material are soaked in 100 ml of distilled water, resulting in a concentration of 10% (w/v).
The soaking occurs at room temperature (°C) for 24 hours with occasional shaking to facilitate the extraction process.
Filtration and centrifugation:after 24 hours of soaking, the mixtures are filtered through two layers of cheesecloth to remove solid particulate materials.
The filtered mixtures are then centrifuged for 20 minutes at 10,000 rpm. This step helps to further remove any remaining particulate matter and debris, resulting in purified extracts.
Adjustment of pH:the purified extracts are adjusted to a pH of 6.8 using 1.0 M HCl (hydrochloric acid). pH adjustment is often done to optimize the stability and solubility of bioactive compounds present in the extract.
Storage:finally, the adjusted extracts are stored in the refrigerator at 4°C for future use. Storing the extracts at low temperature helps to preserve the stability and integrity of the bioactive compounds present in the extract.
This method ensures the extraction of water-soluble compounds from the plant material and results in purified aqueous extracts suitable for further analysis or use in various applications such as pharmaceuticals, cosmetics, or food products.

3.2.2. Antimicrobial Assay

The Kirby-Bauer diffusometric method suitable for natural plant extracts was used to analyse the antimicrobial activity of the willow extract. This method is qualitative and allows the evaluation of the antimicrobial activity of the tested products based on the diameter of the inhibition surfaces for microbial growth. The antimicrobial method is based on the following principles: Stainless steel cylinders are used, which are placed on the surface of a specific growth medium inoculated with the microbial suspension to be tested (medium CaSoA - for the activation of bacterial strains). The tested extract is used in the cylinders. After incubation, the appearance of an inhibition zone of microbial growth was observed, which proves the sensitivity of the tested culture and the special properties of diffusion in the environment of the tested substance.
The level of microbial activity was classified according to the diameter values of the inhibition zones according to the European Pharmacopoeia. The microbial strains selected for the test were Escherichia coli ATCC 8739 and Staphylococcus aureus ATCC 6538. The antimicrobial activity test was performed in triplicate.

2.3. Procedure for Molecular Docking

Molecular docking simulatuons were realized using CLC Drug Discovery Workbench (QIAGEN, Aarhus, Denmark) and MOLEGRO Virtual Docker software (Molexus IVS, Odder, Denmark), respectively. The docking protocol [53] include the mandatoy steps: ligand preparation, target preparation, choice of the suitable binding site, docking simulations for the co-crystallized ligand and for the ligand under investigation, salicin. Validation of the docking procedure was previosly realized in our published paper [54]. Simulations were carried out on the crystal structure of Escherichia coli Topoisomerase IV ParE 24kDa subunit, PDB ID: 1S14 [55]; on the twinned 3.35A structure of S. aureus Gyrase complex with Ciprofloxacin and DNA, PDB ID: 2XCT [Bax, B.D. 2010], and on the Candida albicans dihydrofolate reductase, PDB ID: 1AI9 [56]. For all cases, the native ligands’ pose and interactins were firstly validated and the comparison for the docking score of the salicin was made.

3. Results

After the specific incubation period of 72 hours at 35°C, the results were analyzed. Bacterial development and the inhibition zone of the test extract were observed on the culture medium plates.
The willow plant extract analyzed showed moderate antimicrobial activity and had an inhibition zone diameter of 17 mm for Escherichia coli ATCC 8739 and 15.5 mm for Staphylococcus aureus ATCC 6538.

3.1. Experimental Antimicrobial Activity Results

Figure 12. Zone of inhibition for the extract tested on Escherichia coli ATCC 8739 (right - top). Zone of inhibition for the extract tested on Staphylococcus aureus ATCC 6538 (right - top).
Figure 12. Zone of inhibition for the extract tested on Escherichia coli ATCC 8739 (right - top). Zone of inhibition for the extract tested on Staphylococcus aureus ATCC 6538 (right - top).
Preprints 102587 g012

3.2. Molecular Docking Studies Results

3.2.1. Results on Escherichia coli Simulations

Figure 13 illustrates the interactions occurring between the native ligand, novobiocin and the amino acid residues from the active binding site of the Topoisomerase IV fragment from Escherichia Coli, pose obtained using CLC software. By comparison, in Figure 14, are given the image of the binging salicin in the same binding site and its hydrogen bonds formed with amino acids residues able to interact with its structure (SER 1043, ASP 1069, THR 1163, GLU 1046, ARG 1072, GLY 1073), forming in total 10 hydrogen bonds, as listed in Table 1.
The Table 1 lists the length of hydrogen bond interactions formed by the investigated ligands, the co-crystallized novobiocin and salicin, respectively, within the active binding site of 1S14 receptor, along with the surrounding amino acids group interactions and the results of docking simulation in terms of docking score and the root mean square deviation (RMSD).
Interactions obtained following the simulations carried out on the native ligand Novobiocin, using Molegro software are depicted in Figure 13.
More detailed than the Figure 15, in Table 2 are shown the docking score and the type of interactions (steric interactions and hydrogen bond interactions, respectively) observed using Molegro software for novobiocin, compared with salicin.

3.2.2. Results on Staphylococcus aureus Simulations

In Figure 16, the hydrogen bonds formed by the co-crystallized ciprofloxacin, a fluoroquinolone structure, used as strong antibiotic to treat a number of bacterial infections, in its complex formed with S. aureus gyrase and DNA, given by 2XCT fragment. Figure 17 illustrates the hydrogen bonds formed by salicin with the same receptor, within the active binding site.
In Table 3 are given the results of docking simulations on 2XCT receptor for ciprofloxacin (CPF) and salicin, obtained by means of CLC software.
The results obtained by simulations using Molegro software, for CPF and salicin on the same receptor, S. aureus gyrase, are illustrated for ciprofloxacin in Figure 18, and for salicin in Figure 19, respectively. The details of interactions and score obtained with Molegro software are given in Table 4.

3.2.3. Results on Candida albicans Simulations

The results of docking simulations on dihydrofolate reductase from Candida albicans, PDB ID: 1AI9 for the native ligand (NDP) and for salicin are illustrated in Figure 20 and Figure 21, respectively, representing their hydrogen bonds occurring within the active binding site of the receptor, with the amin acid residues. The details of these interactions and the docking score obtained using CLC software, are given in Table 5.
Figure 22 and Figure 23, respectively, illustrate the hydrogen bonds formed by NDP and salicin, respectively within the binding site of 1AI9 receptor fragment, resulted during simulations with Molegro software. Furthermore, in Table 6, the results of docking studies with Molegro software for Candida albicans, are given as: hydrogen bonding, steric interactions and electrostatic interactions, along with their distance.
Table 7 lists the main parameters and descriptors tacked into account for assessment of the druglikeness of salicin according Lipinski’s rule of five [57]: molecular mass, rotatable bonds count, number of hydrogen bond donors and acceptors, and the water-partition coefficient.

4. Discussion

After the specific incubation period of 72 hours at 35°C, the results were analyzed. Bacterial development and the inhibition zone of the test extract were observed on the culture medium plates. The willow plant extract analyzed showed moderate antimicrobial activity and had an inhibition zone diameter of 17 mm for Escherichia coli ATCC 8739 and 15.5 mm for Staphylococcus aureus ATCC 6538, as illustrated in Figure 12.
Regarding the antibacterial effect, the results obtained in this study are supported by the data presented in the specialized literature.
Some researches [58] tested the antimicrobial effect of bioproducts obtained from the bark of Salix sp. by extractions assisted by ultrasound, made with (alcohol + ethyl acetate). The results obtained by them showed that the bioproducts obtained exhibit antimicrobial effects against S. aureus, B. cereus, B. megatherium, S. fexeneri, B. anthracis, P. aeruginosa, S. boydi and E. coli, which obtain inhibition diameters located between (10-11) mm.
Other researchers [59] in the tests carried out with extracts obtained from the bark of Salix alba, report antimicrobial effects for E. coli, S. aureus and L. monocytes, for which they obtain the inhibition diameters situated between (0.5-3.08) mm.
Another researchers [60,61] in the investigations carried out with the crude bioproducts obtained from the bark of Salix sp. by extraction with a mixture of methanol:water:acetic acid, have reported that these contain catechin, hydroxybenzoic acid, naringenin, piceol, quercitin, salicylic acid and their derivatives.
The tests carried out with these crude extracts reveal that they inhibit the development of S. aureus (the CFU number is reduced from 108 to 102 in the range of the brut extract concentrations situated between (625-2500) µg/mL [60].
If the extraction is carried out in n-hexane, ethyl acetate or methanol, the resulting crude extracts inhibit the development of E. coli for which inhibited diameters between 7.8-11.7 mm are obtained) and S. aureus (the inhibition diameters obtained were situated between 7.2 and 14.5 mm). In the case of bioproducts obtained by extraction in an aqueous medi-um, the scientific literature reports antimicrobial effects for E. coli (inhibition diameter = 13 mm) and S. aureus (MIC = 0.38 mg/mL) [62,63].
In the tests carried out by some researchers [64] on aqueous extracts obtained from 6 species of Salix sp., an antimicrobial effect was put into evidence for S. aureus (MIC= 0.6-0.8) mg/mL. The following compounds were identified in the aqueous extracts obtained sug-ars (glucose, fructose, sucrose), salicin, picein and catechin [64].
In 2023, other studies [65,66] have reported strong antimicrobial effects for S. aureus and S. aureus MRSA [65], as well for C. albicans [57]. If the extractions from the bark of Salix alba is assisted by ultra-sound or microwaves, the brut extracts obtained have antibacterial effects for P. aeruginosa as well (inhibition diameters obtained = 8-19 mm).
Regarding the docking simulations results obtained for Escherichia coli, as show in Figure 13 and Figure 14 and Table 1, using CLC software, the docking score for salicin is close to novo-biocin, suggesting strong interactions, as depicted by the formed hydrogen bonds among with ASP 1069 common amino acid residue. Although with a slightly lower score, salicin forms more hydrogen bonds, 10 compared to novobiocin which forms 6, suggesting a bet-ter complexation. The same situation is observed when performing studies on 1S14 re-ceptor fragment, using Molegro software, as given in Table 2. The score obtained for sali-cin is comparable with novobiocin (- 98.29 versus -100.89), but more interactions given by salicin. Accordingly, a strong antimicrobial effect of salicin against Escherichia coli can be expected.
Concerning the interactions occurring in complex with Staphylococcus aureus DNA gyrase, with both software, CLC and Molegro, respectively, as shown in Table 3 and its corresponding pictures (Figure 16 and Figure 17, respectively), and Table 4, in accordance with Figure 18 and Figure 19, respectively, very strong interactions are observed, both for salicin, and for ciprofloxacin. Additionally, ciprofloxacin shows steric interactions with Mn co-factor and steric interactions with SER1084 and ARG458, on chain B. As expected, the docking score for ciprofloxacin is greater in both cases, showing a stronger effect against Staphylococcus aureus than salicin. The magnitude of the docking score obtained for salicin, leads us to think that it could be used as an antimicrobial agent for less severe infections, with good therapeutic outcomes.
The results of docking simulations for Candida albicans, show lower docking score for salicin than for the native ligand, thus suggesting a weaker affinity of salicin and conse-quently, poor antimicrobial activity against this patogen.

5. Conclusions

The tests carried out with the extracts of Salix sp. obtained showed that raw bioprep-arations have antimicrobial effects for microorganisms such as S. aureus, E. coli and C. albicans, the obtained results being supported by the current scientific literature. Overall, the antimicrobial potency and druglikeness of salicin (no deviation from Lipinski’s rule of five (as shown in Table 7), entitles us not to neglect its therapeutical potential alone and, additionally, as core structure for designing new compounds with better properties.

Author Contributions

Conceptualization, A.D.R.: methodology, N.E and L.P. ; software, L.P.; validation, A.S., N.R. and A.D.R.; formal analysis, A.S.; investigation, L.P.; resources, M.S.; data curation, L.P.; writing—original draft preparation, A.D.R: writing—review and editing, A.D.R.; visualization, N.R.; supervision, A.S.; project administration, A.D.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding authors.

Acknowledgments

This material is part of a larger study of Anca Daniela Raiciu and Amalia Stefaniu, developed in National Chemical-Pharmaceutical Research-Development Institute.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Isebrands, J. G., and Richardson, J.,Poplars and willows: trees for society and the environment. Boston, USA: The Food and Agriculture Organization of the United Nations and CABI, 634, 2014.
  2. Thadeo, M., Azevedo A. A. and Meira, R. M. S. A., Foliar anatomy of neotropical Salicaceae: potentially useful characters for taxonomy. Plant Systemat. Evol. 300, 2073–2089. [CrossRef]
  3. Christenhusz M. J., M., and Byng, J. W.,The number of known plants species in the world and its annual increase,Phytotaxa261, 201–217. [CrossRef]
  4. Kuzovkina Y. A., and Vietto, L.,An update on the cultivar registration of Populus and Salix (Salicaceae). Skvortsovia 2014, 1, 133–148.
  5. Rates, S.M.K., Plants as source of drugs, Toxicon,39: 603-613. [CrossRef]
  6. Saller R., J. Melzer and M. Felder,Pain relief with a proprietary extract of Willow bark in rheumatology, An Open Trial. Schweiz. Zschr. GanzheitsMedizin, 20: 156-162. [CrossRef]
  7. Mahdi J.G., A. Mahdi J.G., A.J. Mahdi, A.J. Mahdi and I.D. Bowen,The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential. Cell Prolif., 39: 147-55. [CrossRef]
  8. et al. ,American Journal of Biochemistry and Biotechnology 9 (1): 41-46,Science Publications 46 AJBB, 2013 https://www.frontiersin.org/articles/10.3389/fphar.2021.593856/full#supplementary-material.
  9. Du, Q., Jerz G., and Winterhalter P., Preparation of three flavonoids from the bark of Salix alba by high-speed countercurrent chromatographic separation. J. Liq. Chromatogr. Relat. Technol. 27, 3257–3264. [CrossRef]
  10. Li, W., Shi, L. L., Han, L. Q., and Zhang, J., Development and validation of a RP-HPLC method for simultaneous determination of salicin and eight flavonoids in leaves of Salix Matsudana Koidz. Acta Chromatograph. 25,735–743. [CrossRef]
  11. Han L. K., Sumiyoshi M., Zhang, J., Liu M. X., Zhang X. F., Zheng Y. N., et al.,Anti-obesity action of Salix matsudana leaves (Part 1). Anti-obesity action by polyphenols of Salix matsudana in high fat-diet treated rodent animals. Phytother. Res. 17, 1188–1194. [CrossRef]
  12. Tawfeek, N., Sobeh,M., Hamdan D. I., Farrag N., Roxo, M., El-Shazly A. M. et al., Phenolic compounds from Populus alba L. and Salix subserrata Willd.(Salicaceae) counteract oxidative stress in Caenorhabditis elegans,Molecules 24, 1999. [CrossRef]
  13. Fernandes, C. C., de Carvalho Cursino, L. M., Novaes, J. d. A. P., Demetrio, C. A.,Júnior, O. L. P., Nunez, C. V., et al.,Salicylates isolated from leaves and stems of Salix martiana Leyb. (Salicaceae). Quím. Nova. 32,983–986. [CrossRef]
  14. Zapesochnaya, G. G., Kurkin, V. A., Braslavskii, V. B., and Filatova, N. V. Phenolic compounds of Salix acutifolia bark. Chem. Nat. Compd. 38, 314–318. [CrossRef]
  15. Wu, Y., Dobermann D., Beale M. H., and Ward J. L., Acutifoliside, a novel benzoic acid glycoside from Salix acutifolia. Nat. Prod. Res. 30, 1731–1739. [CrossRef]
  16. El-Shazly A., El-Sayed, A., and Fikrey, E., Bioactive secondary metabolites.
  17. from Salix tetrasperma Roxb. Z. Naturforsch. C Biosci. 67, 353–359. [CrossRef]
  18. Shah Z. A., Hameed A., Ahmed A., Simjee S. U., Jabeen A., Ullah A., et al.,Cytotoxic and anti-inflammatory salicin glycosides from leaves of Salix acmophylla. Phytochem. Lett. 17, 107–113. [CrossRef]
  19. Noleto-Dias, C., Wu, Y., Bellisai, A.,Macalpine, W., Beale, M., and Ward, J.,Phenylalkanoid glycosides (Non-Salicinoids) from wood chips of Salix triandra× dasyclados hybrid willow. Molecules 24, 1152. [CrossRef]
  20. Evans, T. P., Clausen, T. P., Reichardt, P. B., and Chang, S.,Structurally intriguing glucosides from Alaskan littletree willow (Salix arbusculoides). J. Nat.Prod. 58, 1897–1900. [CrossRef]
  21. Agnolet, S., Wiese, S., Verpoorte, R., and Staerk, D.,Comprehensive analysis of commercial willow bark extracts by new technology platform: combined use of metabolomics, high-performance liquid chromatography–solid-phase extraction–nuclear magnetic resonance spectroscopy and high-resolution radical scavenging assay. J. Chromatogr. A. 1262, 130–137. [CrossRef]
  22. Sobeh, M., Mahmoud, M. F., Rezq, S., Alsemeh, A. E., Sabry, O. M., Mostafa, I.,et al., Salix tetrasperma roxb. Extract alleviates neuropathic pain in rats via modulation of the NF-κB/TNF-α/NOX/iNOS pathway. Antioxidants 8, 482. [CrossRef]
  23. Masika, P., Sultana, N., Afolayan, A., and Houghton, P.,Isolation of two antibacterial compounds from the bark of Salix capensis. South Afr. J. Bot. 71,441–443. [CrossRef]
  24. Zapesochnaya, G. G., Kurkin, V. A., Braslavskii, V. B., and Filatova, N. V.,Phenolic compounds of Salix acutifolia bark. Chem. Nat. Compd. 38,314–318. [CrossRef]
  25. Zarger, M. S. S., Khatoon, F., and Akhtar, N., Phytochemical investigation and growth inhibiting effects of Salix alba leaves against some pathogenic fungal isolates. World J. Pharm. Pharmacol. 2014, 3, 1320–1330.
  26. Ahmed, A., Akbar, S., and Shah, W. A.,Chemical composition and pharmacological potential of aromatic water from Salix caprea inflorescence.Chin. J. Integr. Med. 1–5. [CrossRef]
  27. Pohjamo, S. P., Hemming, J. E., Willför, S. M., Reunanen, M. H., and Holmbom, B.R., Phenolic extractives in Salix caprea wood and knots. Phytochemistry,63, 165–169. [CrossRef]
  28. Shen, T., Tian, Y.-Q., Liu, W.-X., and Zheng, S.-Z., Acyclic diterpene-γ-lactones and flavonoid from Salix cheilophila Omitted. J. Chin. Chem. Soc. 55,401–405. [CrossRef]
  29. Sobeh, M., Mahmoud, M. F., Rezq, S., Alsemeh, A. E., Sabry, O. M., Mostafa, I.,et al.,Salix tetrasperma roxb. Extract alleviates neuropathic pain in rats via modulation of the NF-κB/TNF-α/NOX/iNOS pathway. Antioxidants 8, 482. [CrossRef]
  30. Balbaa, S., Khafagy, S., Haggag, M., and Sahsah, N.,Phytochemical study of certain Salix species cultivated in Egypt. J. Pharmacol. Sci. 1979, 20, 153–164.
  31. Rawat, U., Semwal, S., Semwal, D., Badoni, R., and Bamola, A., A new flavonoid glycoside from salix denticulata aerial parts. Molbank. 2009, M622. [CrossRef]
  32. Singh, H., Raturi, R., and Badoni, P.,Isolation of secondary metabolites from the roots of salix babylonica. Mater. Sci. Eng. 225, 012094. [CrossRef]
  33. Hussain, H., Badawy, A., Elshazly, A., Elsayed, A., Krohn, K., Riaz, M., et al.,Chemical constituents and antimicrobial activity of Salix subserrata. Record Nat. Prod. 2011; 5.
  34. Du, Q., Jerz, G., Shen, L., Xiu, L., and Winterhalter, P.,Isolation and structure determination of a lignan from the bark of Salix alba. Nat. Prod. Res. 21, 451–454. [CrossRef]
  35. Brereton, N. J. B., Berthod, N., Lafleur, B., Pedneault, K., Pitre, F. E., and Labrecque, M.,Extractable phenolic yield variation in five cultivars of mature short rotation coppice willow from four plantations in Quebec. Ind. Crop. Prod. 97, 525–535. [CrossRef]
  36. Karimi, I., Hayatgheybi, H., Kamalak, A., Pooyanmehr, M., and Marandi, Y., Chemical composition and effect of an essential oil of Salix aegyptiaca L., Salicaceae, (musk willow) in hypercholesterolemic rabbit model. Rev. Bras.Farmacogn. 21, 407–414. [CrossRef]
  37. Highfield, E. S., and Kemper, K. J., Long wood herbal task force white willow bark (Salix alba). Available at: www.mcp.edu/herbal/default htm (Accessed July 13, 1999),1999.
  38. Nathan, C., and Ding, A., Nonresolving inflammation. Cell 140, 871–882. [CrossRef]
  39. Kishore, R. N.,Mangilal, T., Anjaneyulu, N., Abhinayani, G., and Sravya, N.,Investigation of anti-inflammatory and invitro antioxidant activities of hydroalcoholic extract of bark of Salix tetrasperma Roxb. Int. J. Pharm.Drug Anal. 2014, 2, 506–509.
  40. Gutiérrez, S. D., Kuri, S. A., and Martín-Herrera, D., The bioguided fractionation and pharmacological activity of an endemic Salix canariensis species. Acta Pharm. 67, 265–273. [CrossRef]
  41. Tunon, H., Olavsdotter, C., and Bohlin, L., Evaluation of anti-inflammatory activity of some Swedish medicinal plants. Inhibition of prostaglandin biosynthesis and PAF-induced exocytosis. J. Ethnopharmacol. 48, 61–76. [CrossRef]
  42. Karawya, M. S., Ammar, N. M., and Hifnawy, M. S., Phytochemical study and evaluation of the anti-inflammatory activity of some medicinal plants growing in Egypt. Med J. Islamic World Acad. Sci. 2010, 109, 1–12.
  43. Li, W., Shi, L. L., Han, L. Q., and Zhang, J., Development and validation of a RP-HPLC method for simultaneous determination of salicin and eight flavonoids in leaves of Salix Matsudana Koidz. Acta Chromatograph. 25,735–743. [CrossRef]
  44. P.K Mukherjee, S Rai, S Bhattacharya, A Wahile, B P Saha.Marker analysis of polyherbal formulation, Triphala -a wellknown Indian traditional medicine. Indian Journal of Traditional Knowledge 2008, 7, 379–383.
  45. R K Harwansh, K Mukherjee, S Bhadra, A Kar, S Bahadur, A Mitra, P K Mukherje. Cytochrome P450 inhibitory potential and RP-HPLC standardization of trikatu-A Rasayana from Indian Ayurveda. Journal of Ethnopharmacology 2014, 153, 674–681. [CrossRef]
  46. A Teruaki, Y Tetsuro, K Kyoich, H Masao. Evaluation of salicin as an antipyretic prodrug that does not cause gastric injury. Planta Med 2002, 68, 714–718. [CrossRef]
  47. N G Bissett. Herbal drugs and phyto-pharmaceuticals.MedPharm CRC Press, Stuttgart, 566, 1994.
  48. M McGuffin, C Hobbs, R Upton, A Goldberg. American Herbal Products Association’s Botanical Safety Handbook; Boca Raton. CRC Press, New York, 231, 1997.
  49. B Meier, D Lehmann, O Sticher, A Bettschart. Identification and determination of 8 phenol glycosides each in Salix purpurea and S. daphnoides by modern high pressure liquid chromatography. Pharmaceutica Acta Helvetiae 1985, 60, 269–275.
  50. S E Zaugg, D Cefalo, E B Walker. Capillary electrophoretic analysis of salicin in Salix spp. Journal of Chromatography 1997, 781, 487–490. [CrossRef]
  51. H Thieme. On the tannin content of willow cortex. Pharmazie 1968, 23, 212.
  52. Willow Bark Monograph, in European Pharmacopoeia, Volume I, pp. 1561-1562, 2017.
  53. Hatamleh, A.A.; Al Farraj, D.; Al-Saif, S.S.; Chidambaram, S.; Radhakrishnan, S.; Akbar, I. Synthesis, Cytotoxic Analysis, and Mo-lecular Docking Studies of Tetrazole Derivatives via N-Mannich Base Condensation as Potential Antimicrobials. Drug Des. Dev. Ther. 2020, 14, 4477–4492. [CrossRef]
  54. Schroder, V.; Radu, N.; Cornea, P.C.; Coman, O.A.; Pirvu, L.C.; Mohammed, M.S.O.; Stefaniu, A.; Pintilie, L.; Bostan, M.; Cara-mihai, M.D.; et al. Studies Regarding the Antimicrobial Behavior of Clotrimazole and Limonene. Antibiotics, 11, 1816. [CrossRef]
  55. Bellon, S.; Parsons, J.D.; Wei, Y.; Hayakawa, K.; Swenson, L.L.; Charifson, P.S.; Lippke, J.A.; Aldape, R.; Gross, C.H. Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin po-tency against topoisomerase IV and DNA gyrase. Agents Chemother. 2004, 48, 1856–1864. [Google Scholar] [CrossRef]
  56. Whitlow, M.; Howard, A.J.; Stewart, D.; Hardman, K.D.; Kuyper, L.F.; Baccanari, D.P.; Fling, M.E.; Tansik, R.L. X-ray crystallographic studies of Candida albicans dihydrofolate reductase. High resolution structures of the holoenzyme and an inhibited ternary complex. J. Biol. Chem. 1997, 272, 30289–30298. [Google Scholar] [CrossRef]
  57. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational aproaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001, 46, 3–26. [Google Scholar] [CrossRef]
  58. Islam, M. S.; Zahan, R.; Nahar, L. M.; Alam, B.; Naznin, M.; Sarka, GC.; Mosaddik, M.A.; Haque, M.E. Antibacterial, insecticidal and in vivo cytotoxicity activities of salix tetrasperma. IJPSR 2011, 2, 2103–2108. [Google Scholar]
  59. Pop, C.; Dan Vodnar, D. Ranga, F.; Socaciu, C. Comparative Antibacterial Activity of Different Plant Extracts in Relation to their Bioactive Molecules, as Determined by LC-MS Analysis. Bulletin UASVM Animal Science and Biotechnologies 2013, 70, 86–94.
  60. Ramos, P.A.B.; Moreirinha, C; Santos, S. A.O.; Almeida, A.; Freire, C. S.R.; Silva, A.M.S.; Silvestre, A. J.D. Valorisation of bark lipophilic fractions from three Portuguese Salix species: A systematic study of the chemical composition and inhibitory activity on Escherichia coli. Ind. Crops Prod., 132, 245–252. [CrossRef]
  61. Ramadhani, S.; Santoni, A.; Efdi, M. Antibacterial Activity and Structure Elucidation of Salicin from Stem Bark of Salix tetrasper-ma ROXB. 2019. [Google Scholar]
  62. Tienaho, J.; Reshamwala, D.; Sarjala, T.; Kilpeläinen, P.; Liimatainen, J.; Dou, J.; Viherä-Aarnio, A.; Linnakoski, R.; Marjomäki, V.; Jyske, T. Salix spp. Bark Hot Water Extracts Show Antiviral, Antibacterial, and Antioxidant Activities-The Bioactive Properties of 16 Clones. Front. Bioeng. Biotechnol. 2021, 9, 797939.
  63. Tawfeek, N.; Mahmoud, M.F.; Hamdan, D.I.; Sobeh, M.; Farrag, N.; Wink, M.; El-Shazly, A.M. Phytochemistry, Pharmacology and Medicinal Uses of Plants of the Genus Salix: An Updated Review. Front. Pharmacol. 2021, 12, 593856. [Google Scholar] [CrossRef]
  64. Dou, J.; Ilina, P.; Hemming, J.; Malinen, K.; Mäkkylä, H. Effect of Hybrid Type and Harvesting Season on Phytochemistry and Antibacterial Activity of Extracted Metabolites from Salix Bark. J. Agric. Food Chem. 2022, 9, 2948–2956. [Google Scholar] [CrossRef]
  65. Dou, J.; Ilina, P.; Cruz, CD.; Nurmi, D.; Vidarte, PZ.; Rissanen, M.; Tammela, P.; Vuorinen, T. Willow Bark-Derived Material with Antibacterial and Antibiofilm Properties for Potential Wound Dressing Applications. J. Agric. Food Chem. 2023, 71, 16554–16567. [Google Scholar] [CrossRef]
  66. Häsler, G.S., Sommerauer, L.; Schnabel, T.; Oostingh, G.J.; Schuster, A. Antioxidative and Antimicrobial Evaluation of Bark Ex-tracts from Common European Trees in Light of Dermal Applications. Antibiotics;12(1),130. [CrossRef]
Figure 1. Structures of reported flavonoids from the genus Salix.
Figure 1. Structures of reported flavonoids from the genus Salix.
Preprints 102587 g001
Figure 2. Structures of reported phenolic glycosides from genus Salix.
Figure 2. Structures of reported phenolic glycosides from genus Salix.
Preprints 102587 g002
Figure 9. Conversion of Salicin→Saligenin→Salicylic Acid [52].
Figure 9. Conversion of Salicin→Saligenin→Salicylic Acid [52].
Preprints 102587 g009
Figure 13. Hydrogen bonds between salicin co-crystallized ligand (novobiocin) receptor,amino acids residues from 1S14 receptor,obtained using CLC software.
Figure 13. Hydrogen bonds between salicin co-crystallized ligand (novobiocin) receptor,amino acids residues from 1S14 receptor,obtained using CLC software.
Preprints 102587 g013
Figure 14. Hydrogen bonds between and amino acids residues from 1S14 obtained using CLC software.
Figure 14. Hydrogen bonds between and amino acids residues from 1S14 obtained using CLC software.
Preprints 102587 g014
Figure 15. Hydrogen bonds between co-crystallized ligand (Novobiocin). and amino acids residues from 1S14 receptor, obtained with Molegro software.
Figure 15. Hydrogen bonds between co-crystallized ligand (Novobiocin). and amino acids residues from 1S14 receptor, obtained with Molegro software.
Preprints 102587 g015
Figure 16. Hydrogen bonds between co-crystallized ligand (ciprofloxacin) and amino acids residues from 2XCT receptor.
Figure 16. Hydrogen bonds between co-crystallized ligand (ciprofloxacin) and amino acids residues from 2XCT receptor.
Preprints 102587 g016
Figure 17. Hydrogen bonds between salicin and amino acids residues from 2XCT receptor.
Figure 17. Hydrogen bonds between salicin and amino acids residues from 2XCT receptor.
Preprints 102587 g017
Figure 18. Hydrogen bonds between co-crystallized ligand (Ciprofloxacin) and amino acids residues from 2XCT receptor.
Figure 18. Hydrogen bonds between co-crystallized ligand (Ciprofloxacin) and amino acids residues from 2XCT receptor.
Preprints 102587 g018
Figure 19. Hydrogen bonds between salicin and amino acids residues from 2XCT receptor.
Figure 19. Hydrogen bonds between salicin and amino acids residues from 2XCT receptor.
Preprints 102587 g019
Figure 20. Hydrogen bonds between co-crystallized ligand (NDP) and amino acids residues from 1AI9 receptor.
Figure 20. Hydrogen bonds between co-crystallized ligand (NDP) and amino acids residues from 1AI9 receptor.
Preprints 102587 g020
Figure 21. Hydrogen bonds between salicin and amino acids residues from 1AI9 receptor.
Figure 21. Hydrogen bonds between salicin and amino acids residues from 1AI9 receptor.
Preprints 102587 g021
Figure 22. Hydrogen bonds between co-crystallized ligand (NDP) and amino acids residues from 1AI9 receptor.
Figure 22. Hydrogen bonds between co-crystallized ligand (NDP) and amino acids residues from 1AI9 receptor.
Preprints 102587 g022
Figure 23. Hydrogen bonds between salicin and amino acids residues from 1AI9 receptor.
Figure 23. Hydrogen bonds between salicin and amino acids residues from 1AI9 receptor.
Preprints 102587 g023
Table 1. The list of intermolecular interactions between the ligand molecules docked with 1S14 (CLC software).
Table 1. The list of intermolecular interactions between the ligand molecules docked with 1S14 (CLC software).
Ligand Score RMSD
(Å)
Amino acids group
interaction
Hydrogen
bond
Bond
Length (Å)
NOV -51.89 0.77 ASP 1077, ARG 1132, PRO 1075, ALA 1086, MET 1074, ARG 1072, GLY 1073, THR 1163, ILE 1090, ASP 1069, GLY 1071, GLU 1046, ASN 1042, SER 1043, ASP 1045 O sp3 (O3) – O sp2 ASP 1077
O sp3 (O3) – O sp2 ASP 1077
O sp3 (O11) – N sp2 ARG 1132
O sp3 (O11) – N sp2 ARG 1132
N sp3(N1) – O sp2 ASP 1069
O sp3 (O6) – O sp2 ASN 1042
3.122
2.686
3.152
3.106
2.645
2.730
Salicin -49.75 0.06 LEU 1091, ILE 1090, VAL 1039, VAL 1067, ASN 1042, VAL 1165, SER 1043, SER 1164, ASP 1069, GLU 1046, THR 1163, MET 1074, GLY 1162, GLY 1071, GLY 1073, ARG 1072, PRO 1075, ARG 1132. O sp3 (O7) – O sp3 SER 1043
O sp3 (O7) – N sp2 SER 1043
O sp3 (O7) – O sp2 ASP 1069
O sp3 (O5) – O sp2 ASP 1069
O sp3 (O5) – O sp2 ASP 1069
O sp3 (O5) – O sp3 THR 1163
O sp3 (O3) – O sp2 GLU 1046
O sp3 (O3) – N sp2 ARG 1072
O sp3 (O3) – N sp2 GLY 1073
O sp3 (O4) – O sp2 GLY 1073
2.678
3.200
3.100
2.824
3.286
2.656
2.660
2.950
2.780
3.044
Table 2. The list of intermolecular interactions between the ligand molecules docked with 1S14 (Molegro software).
Table 2. The list of intermolecular interactions between the ligand molecules docked with 1S14 (Molegro software).
Ligand Score Group
interaction
Hydrogen
bond
Bond
Length, (Å)
Steric interactions Distance
(Å)
NOV -100.89
ALA 1086, ARG 1072, ARG 1132, ASN 1042, ASP 1045, ASP 1069, ASP 1077, GLU 1046, GLY 1073, ILE 1090, MET 1074, PRO 1075, SER 1043, THR1163 O sp3 (O1) – O sp2 ASN 1042
N sp2(N1) – O sp2 ASP 1069
O sp3 (O3) – O sp3 ASP 1077
O sp3 (O11) – N sp2 ARG 1132
O sp2 (O11) – N sp2 ARG 1132
2.729
2.645
2.685
3.105
3.152
C sp2 (C18) – N sp2 ARG 1077
C sp2 (C8) – N sp2 ARG 1072
3.17
3.16
Salicin
-98.29
ARG 1072, ARG 1132, ASN 1042, ASP 1069, GLU 1046, GLY 1071, GLY 1073, GLY 1162, ILE 1090, MET 1074, PRO 1075, SER 1043, THR 1163, VAL 1039, VAL 1067, VAL 1165 O sp3 (O7) – O sp2 VAL 1039
O sp3 (O7) – O sp3 SER 1043
O sp3 (O5) – O sp2 ASP 1069
O sp3 (O5) – O sp3 THR 1063
O sp3 (O3) – N sp2 GLY 1073
O sp3 (O3) - N sp2 ARG 1072
O sp3 (O3) - O sp2 GLU 1046
O sp3 (O3) - O sp2 GLY 1073
2.735
2.818
2.835
2.601
2.743
2.942
2.617
3.082
C sp3 (C12) – C sp3 MET 1074
O sp3 (O5) – C sp3 THR 1163
O sp3 (O3) – C sp3 GLU 1046
O sp3 (O3) – C sp2 GLU 1046
3.150
2.933
3.063
2.903
* NOV ‐ Novobiocin.
Table 3. The list of intermolecular interactions between the ligand molecules docked with 2XCT (CLC software).
Table 3. The list of intermolecular interactions between the ligand molecules docked with 2XCT (CLC software).
Ligand Score RMSD Group
interaction
Hydrogen
bond
Bond
Length
(Å)
CPF -80.60 0.67 ASP 437, SER 1085, SER 1084, GLY 1082, GLY 459, LYS 460, ARG 458, GLU 477, DA 13:H, DC 12:H O sp2 (O1) – O sp3 SER 1084:B
O sp2 (O2) – O sp3 SER 1084:B
2.489
2.604
Salcin -64.52 0.44 ASP 437, SER 1084, GLY 459, DT 10:G, DG 9:G, DT 8:E, DG 7:E, DA 13:H, DC 12>H O sp3 (O7) – O sp2 DT 8:E
O sp3 (O7) – N sp2 DA 13:H
O sp3 (O5) – O sp3 DG 9:G
O sp3 (O4) – O sp3 DG 9:G
O sp3 (O4) – O sp2 DC 12:H
O sp3 (O3) – O sp3 DA 13:H
2.881
3.016
2.844
3.069
3.006
3.070
Table 4. The list of intermolecular interactions between the ligand molecules docked with 2XCT (MOLEGRO).
Table 4. The list of intermolecular interactions between the ligand molecules docked with 2XCT (MOLEGRO).
Ligand Mol Dock Score Molecule Contributions Hydrogen
bond
Bond
Length
(Å)
Electrostatic interactions / Steric interactions Distance
(Å)
CPF -121.47 ARG 458:B, ASP 512:B, ASP 1083:B, GLU 1088:B, GLY 459:B, GLY 1082:B, LYS 417:B, LYS 460:B, LYS 1043:B, SER 1084:B, ARG 1122:D, LYS 1066:D, *DA…DA:G, **DT. DA:H. O sp2 (O1) – O sp3 SER 1084:B
2.489 Electrostatic interactions
O sp2 (O1) – Mn
O sp2 (O2) – Mn

2.089
4.409
Steric interactions
O sp2 (O2) – C sp3 from SER 1084:B
C sp2 (C3) – O sp3 from SER 1084:B
C sp3 (C16) – C sp3 from ARG 458:B

3.024
2.932
3.152
Salicin -94.21 ARG 458:B, ASN 476:B, ASP 437:B, GLU 477:B, GLY 459:B, *DA…DA:G, **DT. DA:H. O sp3 (O7) – O sp3 ASP 437:B
O sp3 (O7) – O sp2 ASP 437:B
O sp3 (O7) – O sp3 *DA…DA:G
O sp3 (O5) – N sp2 *DA…DA:G
O sp3 (O5) – O sp3 **DT. DA:H
O sp3 (O3) – O sp2 ARG 458:B
O sp3 (O6) – O sp2 GLU 477:B
O sp3 (O6) – O sp3 **DT. DA:H
O sp3 (O6) – N sp2 **DT. DA:H
3.190
2.996
3.226
2.460
2.950
3.094
3.168
3.052
3.429
C sp3 (C9) – N sp2 ARG 458:B
C sp3 (C13) – O sp2 GLU 477:B
2.695
3.219
* nucleic acids: chain G: DA-DT-DG-DG-DG-DC-DC-DC-DC-DC-DA. ** nucleic acids: chain H: DT-DG-DG-DC-DC-DC-DC-DC-DA-DA-DA-DA.
Table 5. The list of intermolecular interactions between the compounds docked with 1AI9 (CLC software).
Table 5. The list of intermolecular interactions between the compounds docked with 1AI9 (CLC software).
Ligand Score RMSD
(Å)
Group interaction Hydrogen Bond Bond
Length
(Å)
Co-crystallized
NDP
-79.35 2.86 LEU 121, GLU 120, SER 95, TYR 118, GLU 116, ILE 117, SER 94, ARG 79, ILE 9, ALA 93, VAL 10, SER 78, LEU 77, ILE 112, GLY 113, MET 54, ALA 11, GLY 114, ILE 19, THR 147, GLY 20, TYR 21, PHE 36, ARG 56, LYS 57, THR 58, MET 25, GLY 23, PRO 26, LYS 24 N sp2 (N7N) – O sp2 ILE 112
O sp3 (O2D) – O sp2 ILE 19
O sp3 (O4D) – N sp2 ALA 115
O sp3 (O5D) – N sp2 ALA 115
O sp2 (O2N) – O sp3 THR 58
O sp2 (O2N – N sp2 THR 58
O sp2 (O2A) – N sp2 ALA 115
O sp2 (O2A) – N sp2 GLU 116
O sp3 (O3B) – O sp2 GLU 116
O sp3 (O3B) – N sp3 LYS 57
O sp2 (O2X) – N sp3 LYS 57
O sp2 (O2X) – N sp2 ARG 56
O sp2 (O1X) – N sp2 ARG 79
O sp2 (O3X) – N sp2 ARG 79
O sp2 (O3X) – N sp2 ARG 79
N sp2 (N3A) – N sp2 SER 78
3.069
2.649
3.335
3.394
2.977
3.194
3.111
2.733
2.892
2.924
2.772
2.365
2.698
2,984
3.061
3.286
Salicin -57.52 0.26 SER 89, ARG 79, GLU 120, LEU 121, ILE 96, GLU 116, SER 95, SER 94, SER 78, SER 80, LEU 77, GLY 55, ALA 93, ARG 56, LYS 57, THR 58, MET 54 O sp3 (O7) - O sp3 GLU 116
O sp3 (O7) – N sp2 ARG 79
O sp3 (O7) – N sp2 ARG 79
O sp3 (O5) – N sp2 ARG 79
O sp3 (O5) – N sp2 ARG 79
O sp3 (O3) – N sp2 ARG 56
O sp3 (O4) – N sp2 ARG 56
O sp3 (O4) – N sp3 LYS 57
O sp3 (O4) – N sp2 LYS 57
O sp3 (O6) – N sp2 LYS 57
O sp3 (O6) – N sp2 ARG 56
O sp3 (O2) – N sp2 ARG 79
O sp3 (O2) – N sp2 ARG 79
O sp3 (O2) – N sp2 ARG 79
3.096
3.157
3.045
2.642
2.727
2.608
3.246
3.295
3.123
2.875
3.116
3.174
3.066
3.145
Table 6. The list of docking interactions between the ligand molecules and 1AI9 using MOLEGRO VIRTUAL DOCKER Software.
Table 6. The list of docking interactions between the ligand molecules and 1AI9 using MOLEGRO VIRTUAL DOCKER Software.
Ligand Mol Dock Score Molecule contributions Hydrogen
bond
Bond
Length
(Å)
Electrostatic interactions / Steric interactions Distance
(Å)
Co-crystallized NDP -155.24 ALA 11, ALA 12, ALA 93, ALA 115, ARG 49, ARG 56, ARG 67, ARG 72, ARG 79, ARG 191, ASP 87, ASP 146, GLU 32, GLU 60, GLU 82, GLU 84, GLU 97, GLU 116, GLU 120, GLY 20, GLY 23, GLY 55, GLY 113, GLY 114, HIS 92, ILE 19, ILE 112, ILE 117, LEU 77, LEU 121, LYS 3, LYS 14, LYS 22, LYS 24, LYS 31, LYS 37, LYS 45, LYS 57, LYS 65, LYS 150, LYS 158, LYS 178, LYS 192, MET 25, SER 78, SER 80, SER 94, SER 95, THR 58, THR 147, TRP 27, TYR 21, TYR 118, VAL 10 N sp2 (N7N) – O sp2 ILE 19
N sp2 (N7N) – O sp2 ALA 11
O sp3 (O7N) – N sp2 ALA 11
O sp3 (O7N) – N sp2 ALA 11
O sp3 (O4D) – N sp2 ALA 115
O sp3 (O5D) – N sp2 ALA 115
O sp2 (O2A) – N sp2 GLY 114
O sp2 (O2A) – O sp3 THR 58
O sp2 (O2A) – N sp2 THR 58
O sp2 (O2N) – N sp2 GLU 116
O sp2 (O1A) – N sp2 GLU 116
O sp2 (O1A) – N sp2 ILE 117
O sp3 (O3B) – N sp3 LYS 57
O sp2 (O2X) – N sp2 ARG 56
O sp2 (O1X) – N sp2 ARG 56
O sp2 (O1X) – O sp3 SER 78
O sp2 (O3X) – N sp2 ARG 79
O sp2 (O3X) – N sp2 ARG 79
3.204
2.887
3.093
3.514
3.437
2.930
2.813
2.565
3.218
3.109
3.405
3.302
2.585
3.199
2.893
2.455
2.757
2.545
Electrostatic interactions
O sp2 (O2X) – N sp2 ARG 79
O sp2 (O2X) – N sp2 ARG 56
O sp3 (O2X) – N sp3 LYS 57
O sp2 (O1X) – N sp2 ARG 79
O sp2 (O1X) – N sp2 ARG 79
O sp2 (O3X) – N sp2 ARG 56
3.716
3.199
4.399
2.545
4.247
3.681
Steric interactions
O sp2 (O1A) – N sp2 GLY 114
O sp2 (O2A) – C sp3 GLY 114
O sp2 (O1X) – C sp3 SER 78
3.109
3.181
3.153
Salicin - 94.82 ARG 56, ARG 79, GLU 116, GLU 120, GLY 55, ILE 117, LEU 77, LEU 121, LYS 57, SER 78, SER 94, SER 95 O sp3 (O7) - O sp3 GLU 116
O sp3 (O7) – N sp2 ARG 79
O sp3 (O7) – N sp2 ARG 79
O sp3 (O5) – N sp2 ARG 79
O sp3 (O5) – N sp2 ARG 79
O sp3 (O3) – N sp2 ARG 56
O sp3 (O4) – N sp2 ARG 56
O sp3 (O4) – N sp2 LYS 57
O sp3 (O4) – O sp2 GLU 116
2.810
3.000
3.052
2.961
2.909
3.318
2.855
2.798
3.110
O sp3 (O4) – C sp3 LYS 57 2.939
Table 7. Calculated properties of salicin.
Table 7. Calculated properties of salicin.
Compounds Atoms Weight
[Daltons]
Flexible
bonds
Lipinski violations Hydrogen
donors
Hydrogen acceptors Log P
Salicin 38 286.28 4 0 5 7 1.68
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2024 MDPI (Basel, Switzerland) unless otherwise stated